1. Poland Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Medicalgorithmics SA

Medicalgorithmics SA

GGPW:MDG
23.45
PLN
-1.35
(-5.44%)
-0.97EPS
277.18MMarket Cap
Nov 26Next Earn
Medicalgorithmics SA
GPW:MDG
(Warsaw Stock Exchange)

Recent

price

23.45

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
PLN
1.65
2.33
3.81
4.59
8.6
14.27
35.46
56.38
55.28
48.2
27
10.63
11
4.33
2.41
3.11
3.46
Revenue per Share
0.77
1.21
2.58
3.18
4.2
4.03
11.12
7.08
4
1.19
-3.12
-39.73
-2.08
-0.06
-1.62
-1.17
-0.97
Basic EPS, GAAP
0.67
0.33
1.92
1.56
-2.33
4.24
7.48
-2.56
10.48
1.32
-0.96
-1.42
-1.06
-1.12
-2.32
-1.57
-0.02
Free Cash Flow per Basic Share
- -
- -
- -
1.1
1.35
1.6
1.77
3.21
1.42
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
1.14
4.77
21.56
23.65
26.27
28.7
49.07
46.84
52.64
54.3
47.91
9.52
9.51
9.3
7.75
6.49
6.32
Book Value per Share
0.8
4.11
21.2
22.14
23.57
25.59
-16.75
-7.76
-5.71
-3.85
1.29
-0.64
3.09
2
-0.13
-2.28
-2.77
Tangible Book Value per Share
2
2
3
3
3
3
4
4
4
4
4
5
6
10
10
10
10
Basic Weighted Avg Shares
4
6
11
16
30
49
128
203
199
174
112
48
63
43
24
31
34
Sales/Revenue/Turnover
51.53
53.19
64.51
63.74
46.75
43.78
36.31
20.46
12.79
0.2
-30.79
25.09
25.59
1.28
-67.88
-26.25
-13.8
Operating Margin (%)
- -
- -
- -
- -
1
2
5
12
12
19
16
18
4
2
4
5
5
Depreciation Expense
2
3
7
11
15
14
40
26
14
4
-13
-181
-12
-1
-16
-12
-10
Net Income, GAAP
6.51
11.7
19.19
19.3
19.3
19.46
6.8
8.03
12.17
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
46.5
51.78
67.62
69.27
48.89
28.23
31.35
12.56
7.23
2.46
-11.56
-373.61
-18.91
-1.34
-67
-37.71
-27.96
Profit Margin (%)
1
7
64
46
42
52
16
43
17
8
4
-4
46
31
13
4
2
Working Capital
- -
- -
- -
- -
- -
- -
50
50
8
24
12
8
- -
- -
3
17
19
LT Debt
3
12
74
81
91
99
215
204
231
225
207
47
95
93
77
65
63
Total Equity
- -
36.35
13.27
10.4
13.03
17.89
23.11
14.29
7.76
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
40.93
17.49
14.05
16.92
14.68
22.04
7.89
4.64
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
40.86
17.3
14.06
16.92
14.66
29.05
14.77
8.04
2.22
-6.41
-141.82
-16.7
-0.62
-18.95
-16.48
-14.21
Return on Common Equity (%)

Capital Structure

PLN

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
2
3
LT Borrowings
16
17
19
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
395
334
277

Working Capital

PLN

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
17
17
17
Cash, Cash Equivalents & STI
3
3
3
Accounts Receivable, Net
7
9
9
Inventories
7
5
5
Total Current Liabilities
8
13
16
Payables & Accruals
- -
- -
- -
ST Debt
- -
2
3
Deferred Revenue
- -
- -
- -

Growth Rates

PLN

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.19%
-2.5%
-16.26%
Free Cash Flow
-61.46%
43.2%
-32.28%
Net Income, GAAP
340.04%
752.9%
-27.34%
Sales/Revenue/Turnover
9.43%
-14.7%
29.09%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7
6
5
6
24
2025
7
7
7
10
31
2026
10
- -
- -
- -
- -

Quarterly Earnings Per Share

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.4
-0.53
-0.21
-0.47
-1.62
2025
-0.42
-0.25
-0.41
-0.09
-1.17
2026
-0.22
- -
- -
- -
- -

Quarterly Dividends Per Share

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Medicalgorithmics S.A. delivers advanced cardiac diagnostic and monitoring solutions across global markets, including Poland, the United States, and numerous other countries. The company’s flagship offering, PocketECG, is a comprehensive system designed for arrhythmia detection, providing full-disclosure ECG data, in-depth analysis, and detailed diagnostic reporting, functioning seamlessly as a long-term Holter, event monitor, and mobile cardiac telemetry device. Medicalgorithmics also pioneers AI-driven technologies like DeepRhythmAI (DRAI), an FDA-approved algorithm for rapid and precise heart rhythm analysis, and the cloud-based DeepRhythm Platform (DRP), which integrates with diverse hardware for enhanced ECG interpretation. Complementing these, Kardiobeat.ai offers extended Holter monitoring with AI diagnostics, while VCAST provides an innovative AI-based virtual cardiac stress test for non-invasive coronary artery disease assessment. Since its establishment in 2005, and headquartered in Warsaw, Poland, the firm has strategically pivoted to emphasize high-margin software licensing and AI algorithm integration with third-party systems, expanding its service revenue and global client base, including significant growth in the US market and new entries into regions like the Middle East.